Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis

BACKGROUND & AIMS: Ticagrelor has been acknowledged as a new oral antagonist of P2Y12-adenosine diphosphate receptor, as a strategy with more rapid onset as well as more significant platelet inhibition function in acute coronary syndrome (ACS) patients. The clinical benefit of ticagrelor compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dong, Yang, Xiao-Hong, Zhang, Ji-Dong, Li, Rui-Bin, Jia, Min, Cui, Xiao-Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267904/
https://www.ncbi.nlm.nih.gov/pubmed/30497387
http://dx.doi.org/10.1186/s12872-018-0948-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267904/
https://www.ncbi.nlm.nih.gov/pubmed/30497387
http://dx.doi.org/10.1186/s12872-018-0948-4

Ejemplares similares